Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2023 | Addressing the financial and manufacturing challenges associated with CAR-T therapy in India

Gaurav Narula • 9 Feb 2023
CAR-T Meeting 2023
General CAR-T

Gaurav Narula, MD, Tata Memorial Center, Mumbai, India, discusses the financial and manufacturing challenges associated with CAR-T therapy in India, and further explains strategies being explored to overcome these. Dr Narula comments on the possibility of reducing the cost of these agents with government aid and charities, and further highlights how adapting manufacturing processes may improve patient access to CAR-T cells. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Scientific Advisory Board to ImmunoACT

More from Gaurav Narula

0:55
Intracranial disease in Hodgkin lymphoma: a case study
Gaurav Narula • 15 Feb 2024
1:53
An update on the progress made in CAR T-cell therapy in India
Gaurav Narula • 15 Feb 2024
2:41
Safety and efficacy of Actaly-cel™ in R/R pediatric B-ALL
Gaurav Narula • 15 Feb 2024
1:37
Exploring novel humanized anti-CD19 CAR-T cells as a strategy to minimize CRS and other toxicities
Gaurav Narula • 9 Feb 2023

Related Videos

2:14
The influence of graft source and composition on GvHD
Mattia Algeri • 15 Apr 2024
1:49
Guidelines on the diagnosis and management of neutropenia
Carlo Dufour • 15 Apr 2024
1:51
The importance of sustainable healthcare
Shireen Kassam • 24 Apr 2024
2:20
EBMT diagnostic criteria for TMA post-alloSCT and the role of complement activation
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals